Fade Upon TOF Stimulation Induced by Succinylcholine

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

January 4, 2017

Study Completion Date

January 4, 2017

Conditions
Muscle Relaxants
Interventions
DRUG

Succinylcholine

will be administered succinylcholine in a dose of 0.1 mg/kg in Arm 1, 0.15 mg/kg in Arm 2, 0.2 mg/kg in Arm 3, 0.25 mg/kgin Arm 4, 0.3 mg/kg in Arm 5.

Trial Locations (1)

43614

University of Toledo, Health Science Campus, Toledo

All Listed Sponsors
lead

University of Toledo Health Science Campus

OTHER

NCT02425449 - Fade Upon TOF Stimulation Induced by Succinylcholine | Biotech Hunter | Biotech Hunter